<DOC>
	<DOCNO>NCT01400919</DOCNO>
	<brief_summary>The DURABILITY Iliac study prospective , multi-center , non-randomized study confirm safety effectiveness stenting use Protégé® EverFlex™ Protégé® GPS™ Self-Expanding Stent Systems treatment atherosclerotic lesion common and/or external iliac artery .</brief_summary>
	<brief_title>DURABILITY™ Iliac Study</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>Patient claudication define Rutherford Clinical Category Score 2 , 3 4 . Evidence ≥ 50 % stenosis , restenosis occlusion target lesion ( ) locate common iliac artery and/or external iliac artery . Willing comply followup evaluation specify time . Provides write informed consent prior enrollment study . Previous implantation stent ( ) target vessel . Received endovascular treatment target lesion within six month prior index procedure . Known hypersensitivity contrast material adequately pretreated . Known hypersensitivity nickeltitanium . Life expectancy le 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Peripheral arterial disease</keyword>
	<keyword>claudication</keyword>
	<keyword>stent</keyword>
	<keyword>EverFlex</keyword>
	<keyword>GPS</keyword>
	<keyword>Iliac Artery</keyword>
</DOC>